These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 14962809)

  • 1. MEPE has the properties of an osteoblastic phosphatonin and minhibin.
    Rowe PS; Kumagai Y; Gutierrez G; Garrett IR; Blacher R; Rosen D; Cundy J; Navvab S; Chen D; Drezner MK; Quarles LD; Mundy GR
    Bone; 2004 Feb; 34(2):303-19. PubMed ID: 14962809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
    Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
    J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).
    Rowe PS; Garrett IR; Schwarz PM; Carnes DL; Lafer EM; Mundy GR; Gutierrez GE
    Bone; 2005 Jan; 36(1):33-46. PubMed ID: 15664000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone.
    Argiro L; Desbarats M; Glorieux FH; Ecarot B
    Genomics; 2001 Jun; 74(3):342-51. PubMed ID: 11414762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
    Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
    Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo.
    Hayashibara T; Hiraga T; Yi B; Nomizu M; Kumagai Y; Nishimura R; Yoneda T
    J Bone Miner Res; 2004 Mar; 19(3):455-62. PubMed ID: 15040834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASARM-truncated MEPE and AC-100 enhance osteogenesis by promoting osteoprogenitor adhesion.
    Sprowson AP; McCaskie AW; Birch MA
    J Orthop Res; 2008 Sep; 26(9):1256-62. PubMed ID: 18383145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
    Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
    J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets.
    Bresler D; Bruder J; Mohnike K; Fraser WD; Rowe PS
    J Endocrinol; 2004 Dec; 183(3):R1-9. PubMed ID: 15590969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
    Addison WN; Nakano Y; Loisel T; Crine P; McKee MD
    J Bone Miner Res; 2008 Oct; 23(10):1638-49. PubMed ID: 18597632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif.
    Zelenchuk LV; Hedge AM; Rowe PS
    Bone; 2015 Oct; 79():131-42. PubMed ID: 26051469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.
    Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL
    Genomics; 2000 Jul; 67(1):54-68. PubMed ID: 10945470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active sites of human MEPE-ASARM regulating bone matrix mineralization.
    Minamizaki T; Sakurai K; Hayashi I; Toshishige M; Yoshioka H; Kozai K; Yoshiko Y
    Mol Cell Endocrinol; 2020 Nov; 517():110931. PubMed ID: 32712387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.
    David V; Martin A; Hedge AM; Drezner MK; Rowe PS
    Am J Physiol Renal Physiol; 2011 Mar; 300(3):F783-91. PubMed ID: 21177780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The wrickkened pathways of FGF23, MEPE and PHEX.
    Rowe PS
    Crit Rev Oral Biol Med; 2004 Sep; 15(5):264-81. PubMed ID: 15470265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.
    Boukpessi T; Gaucher C; Léger T; Salmon B; Le Faouder J; Willig C; Rowe PS; Garabédian M; Meilhac O; Chaussain C
    Am J Pathol; 2010 Aug; 177(2):803-12. PubMed ID: 20581062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia.
    Salmon B; Bardet C; Khaddam M; Naji J; Coyac BR; Baroukh B; Letourneur F; Lesieur J; Decup F; Le Denmat D; Nicoletti A; Poliard A; Rowe PS; Huet E; Vital SO; Linglart A; McKee MD; Chaussain C
    PLoS One; 2013; 8(2):e56749. PubMed ID: 23451077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia.
    Liu S; Brown TA; Zhou J; Xiao ZS; Awad H; Guilak F; Quarles LD
    J Am Soc Nephrol; 2005 Jun; 16(6):1645-53. PubMed ID: 15843468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.